Indoles

Details Indoles Indoles

2007-11-30

2011-12-13

Chang, Celia (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S321000, C546S198000, C546S201000

Reexamination Certificate

active

08076360

ABSTRACT:
The present invention is concerned with novel indol-2-yl-carbonyl-piperidine derivatives as V1a receptor antagonists, their manufacture, pharmaceutical compositions containing them and their use as medicaments. The active compounds of the present invention are useful in the prevention and/or treatment of anxiety and depressive disorders and other diseases. Present invention is concerned with compounds of the general formula (I)wherein R1to R6, R8to R14, R12′, R13′, X and Y are as defined in the specification.

REFERENCES:
patent: 7799923 (2010-09-01), Bissantz et al.
patent: 2008/0139617 (2008-06-01), Bissantz et al.
patent: WO 00/14067 (2000-03-01), None
patent: WO 01/85725 (2001-11-01), None
patent: WO 02/34718 (2002-05-01), None
patent: WO 2004/035549 (2004-04-01), None
patent: WO 2005/005411 (2005-01-01), None
Bottcher et al. “Preparation of benzyl . . . ” CA 130:81409 (1999).
Ebner et al., (2002), Eur. J. Neurosci. vol. 15 pp. 384-388.
Bielsky et al., (2004), Neuropsychopharmacology, vol. 29 pp. 483-493.
Michelini et al., (1999), Annals NY Acad. Sci. vol. 897 pp. 198-211.
Van Kerckhoven et al., (2002) Eur. J. Pharmacol. vol. 449 pp. 135-141.
Liebsch et al., (1995), Regulatory Peptides vol. 59 pp. 229-239.

Affiliated with

Also associated with

Rating

Indoles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indoles will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4308654